|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/47 | |
| C07K 19/00 | |||
| A61K 38/17 | |||
| A61P 25/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2621945 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11833072.9 |
| Europos patento paraiškos padavimo data | 2011-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-08-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/053764 |
| Data | 2011-09-28 |
| (87) | Numeris | WO 2012/050921 |
| Data | 2012-04-19 |
| (30) | Numeris | Data | Šalis |
| 387439 P | 2010-09-28 | US |
| (72) |
TYMIANSKI, Michael, CA
LI, Rongwen, CA
GARMAN, Jonathan David, CA
|
| (73) |
NoNO Inc.,
88 Strath Avenue, Toronto ON M8X 1R5,
CA
|
| (54) | ND2 PEPTIDES AND METHODS OF TREATING NEUROLOGICAL DISEASE |
| ND2 PEPTIDES AND METHODS OF TREATING NEUROLOGICAL DISEASE |